￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
After drug resistance to sotoracib (AMG510): the importance of genetic testing and strategic adjustments

2026-02-01 22:25:32

Check Details
Subsidence time and treatment recommendations for side effects of sotorasib (AMG510)

2026-02-01 22:25:32

Check Details
Sotoracib (AMG510): A new chapter in lung cancer treatment targeting KRAS G12C mutations

2026-02-01 22:25:32

Check Details
How long does it take for Sotoraxibu (AMG510) to take effect?

2026-02-01 22:25:32

Check Details
The time it takes for the therapeutic effects of Sotoracib (AMG510) to appear varies from person to person.

2026-02-01 22:25:32

Check Details
What is the shelf life of the targeted drug sotoraxib (AMG510)?

2026-02-01 22:25:32

Check Details
Is the Chinese name of AMG510 targeted drug sotoracib?

2026-02-01 22:25:32

Check Details
An in-depth analysis of KRAS-targeted drugs: Is the Chinese name of AMG510 sotoraxib?

2026-02-01 22:25:32

Check Details
Which generation of targeted drugs does osimertinib/osimertinib belong to?

2026-02-01 22:25:32

Check Details
Osimertinib/osimertinib latest medical insurance price 2024

2026-02-01 22:25:32

Check Details
Osimertinib/osimertinib latest price in 2024

2026-02-01 22:25:32

Check Details
The latest news on osimertinib/osimertinib medical insurance reimbursement in 2024

2026-02-01 22:25:32

Check Details
Category
相关知识